Track topics on Twitter Track topics that are important to you
Leukaemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukaemia (AML) to rare therapy-resistant leukaemia stem cells that are already present at diagnosis and before chemotherapy begins. They have also identified...
Original Article: Mystery of relapse in acute myeloid leukaemia uncoveredNEXT ARTICLE
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...